Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Elderly Patients
100%
Time-to-treatment
100%
Treatment Intensification
100%
Time Study
100%
Real-world Observational Study
100%
Median Time
44%
Specific Patient
44%
Polypharmacy
44%
Medical Complexity
44%
Fall Risk
33%
Urinary Incontinence
33%
Cognitive Impairment
22%
Care Delivery Model
22%
Oral Antidiabetic Drugs
22%
Hemoglobin A1c (HbA1c)
11%
Type 2 Diabetic Patients
11%
Non-associated
11%
Integrated Health Service Delivery
11%
Healthcare Utilization
11%
Retrospective Cohort Study
11%
Age-related Illnesses
11%
Clinical Characteristics
11%
Insurance
11%
Clinical Health
11%
Medicare Beneficiaries
11%
Diabetes Management
11%
American Diabetes Association
11%
Consensus Statement
11%
Adjusted Hazard Ratio
11%
Population Heterogeneity
11%
Type 2 Diabetes Mellitus Patients
11%
American Geriatrics Society
11%
Intensified Treatment
11%
Appropriate Treatment
11%
Integrated Care
11%
Elderly Diabetes
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Observational Study
100%
Elderly Patient
100%
Time to Treatment
100%
Polypharmacy
57%
Urine Incontinence
42%
Enuresis
42%
Diabetes
28%
Cognitive Defect
28%
Delivery of Health Care
28%
Oral Antidiabetic Agent
28%
Hazard Ratio
14%
Retrospective Cohort Study
14%
Medicare
14%
Geriatrics
14%
Health Care Utilization
14%
Geriatric Syndrome
14%
Hemoglobin A1c
14%
Patient with Type 2 Diabetes
14%
Nursing and Health Professions
Elderly Patient
100%
Non Insulin Dependent Diabetes Mellitus
100%
Time to Treatment
100%
Polypharmacy
57%
Urine Incontinence
42%
Enuresis
42%
Cognitive Defect
28%
Oral Antidiabetic Agent
28%
Integrated Health Care System
14%
Syndrome
14%
Health Care Utilization
14%
Medicare
14%
Cohort Analysis
14%
Hazard Ratio
14%
Hemoglobin A1c
14%
Patient with Type 2 Diabetes
14%
Health Care Delivery
14%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Non Insulin Dependent Diabetes Mellitus
100%
Polypharmacy
57%
Urine Incontinence
42%
Enuresis
42%
Cognitive Defect
28%
Oral Antidiabetic Agent
28%
Syndrome
14%
Hemoglobin A1c
14%
Cohort Study
14%